ATE493127T1 - Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs - Google Patents

Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs

Info

Publication number
ATE493127T1
ATE493127T1 AT06742090T AT06742090T ATE493127T1 AT E493127 T1 ATE493127 T1 AT E493127T1 AT 06742090 T AT06742090 T AT 06742090T AT 06742090 T AT06742090 T AT 06742090T AT E493127 T1 ATE493127 T1 AT E493127T1
Authority
AT
Austria
Prior art keywords
ornidazole
levo
preparation
antiparasic
producing
Prior art date
Application number
AT06742090T
Other languages
English (en)
Inventor
Cang Zhang
Xiaoxin Tao
Original Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35705578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE493127(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nanjing Sanhome Pharmaceutical Co Ltd filed Critical Nanjing Sanhome Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE493127T1 publication Critical patent/ATE493127T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT06742090T 2005-07-08 2006-06-05 Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs ATE493127T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2005100835172A CN1305469C (zh) 2005-07-08 2005-07-08 左旋奥硝唑在制备抗寄生虫感染的药物中的应用
PCT/CN2006/001204 WO2007006197A1 (fr) 2005-07-08 2006-06-05 Utilisation de lévo-ornidazole pour la préparation de médicaments contre les infections parasitaires

Publications (1)

Publication Number Publication Date
ATE493127T1 true ATE493127T1 (de) 2011-01-15

Family

ID=35705578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06742090T ATE493127T1 (de) 2005-07-08 2006-06-05 Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs

Country Status (7)

Country Link
US (1) US20080177083A1 (de)
EP (1) EP1902712B1 (de)
CN (1) CN1305469C (de)
AT (1) ATE493127T1 (de)
DE (1) DE602006019250D1 (de)
ES (1) ES2358441T3 (de)
WO (1) WO2007006197A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100451023C (zh) * 2006-01-06 2009-01-14 陕西新安医药科技有限公司 左旋奥硝唑磷酸酯及其制备方法和用途
CN1329379C (zh) * 2006-01-06 2007-08-01 沈阳中海生物技术开发有限公司 抗厌氧菌化合物
CN100534429C (zh) * 2006-05-12 2009-09-02 南京圣和药业有限公司 左旋奥硝唑阴道给药制剂及其制备方法和制药用途
CN100503606C (zh) * 2006-05-24 2009-06-24 沈阳中海生物技术开发有限公司 噻二唑取代的咪唑类抗厌氧菌化合物
CN100387233C (zh) * 2006-06-09 2008-05-14 南京圣和药业有限公司 左旋吗啉硝唑在制备抗寄生虫感染药物中的用途
CN102813622B (zh) * 2012-08-09 2013-06-26 西安万隆制药股份有限公司 一种奥硝唑氯化钠注射液组合物
EP3244890B1 (de) 2014-12-20 2025-05-21 Gregg, John Malcolm Hall Ornidazol zur behandlung von infektionen verursacht durch burkholderia mallei oder burkholderia pseudomallei
US20210369675A1 (en) * 2016-08-20 2021-12-02 John Malcolm Hall Gregg Antimicrobial drug methods of use & therapeutic compositions
CN114478392B (zh) * 2020-10-26 2023-09-29 南京锐志生物医药有限公司 一种抗厌氧菌化合物的酯类前药、药物组合物及其制备方法和应用
CN114452315B (zh) * 2022-03-16 2023-04-07 郑州大学第一附属医院 一种阴道泡腾栓及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435049A (en) * 1965-05-19 1969-03-25 Hoffmann La Roche Nitroimidazole derivatives
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
CS237849B1 (sk) * 1984-01-09 1985-10-16 Marian Simko Dopravné zariadenie, najma pre dopravu foriem vo vypeňovacej linke
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
US6576250B1 (en) * 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
CN1179951C (zh) * 2002-07-19 2004-12-15 中国科学院上海有机化学研究所 噻克硝唑的光学对映体、制备方法及其用途
CN1212405C (zh) * 2002-08-23 2005-07-27 中国科学院上海有机化学研究所 外消旋奥硝唑的酶法拆分方法
CN1332662C (zh) * 2005-04-29 2007-08-22 南京圣和药业有限公司 左旋奥硝唑的静脉给药制剂及其制备方法

Also Published As

Publication number Publication date
EP1902712B1 (de) 2010-12-29
CN1709245A (zh) 2005-12-21
WO2007006197A1 (fr) 2007-01-18
EP1902712A1 (de) 2008-03-26
US20080177083A1 (en) 2008-07-24
CN1305469C (zh) 2007-03-21
DE602006019250D1 (de) 2011-02-10
EP1902712A4 (de) 2008-09-10
ES2358441T3 (es) 2011-05-10

Similar Documents

Publication Publication Date Title
RU2325389C2 (ru) Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
MY157661A (en) Bendamustine pharmaceutical compositions
EP1819227A4 (de) Pharmazeutische formulierungen von decitabin
DE60315145D1 (de) Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
NO20075136L (no) Nye liposompreparater
EA200970726A1 (ru) Твердый препарат, содержащий алоглиптин и пиоглитазон
UY29410A1 (es) Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones.
SE0001899D0 (sv) New compounds
EP2004172A4 (de) Wirkstofffreisetzungsverfahren, strukturen und zusammensetzungen für nasolacrimales system
JP2005537234A5 (de)
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
TN2009000483A1 (fr) Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602006019250D1 (de) Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs
DE502005010170D1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
EP1543158A4 (de) Regulierte aptamer-therapeutika
EA200801698A1 (ru) Лекарственные композиции для применения в вагине
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
HRP20041048B1 (hr) POLIMORF 4-[2-[4-[1-(2-ETOKSIETIL)-1H-BENZIMIDAZOL-2-IL]-1-PIPERIDINIL]ETIL]-α, α- DIMETIL- BENZENOCTENE KISELINE
EP1875910A4 (de) Anwendung von levo-ornidazol bei der herstellung eines medikaments gegen infektion mit anaeroben bakterien
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
UA94036C2 (ru) Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
SE0400708D0 (sv) New compounds and use thereof
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties